Results 211 to 220 of about 2,037,182 (380)

Perampanel and childhood absence epilepsy: A real life experience. [PDF]

open access: yesFront Neurol, 2022
Operto FF   +14 more
europepmc   +1 more source

Symptoms of anxiety and depression in childhood absence epilepsy [PDF]

open access: bronze, 2011
Clemente Vega   +9 more
openalex   +1 more source

Subthalamic Electrophysiological Mapping of Gait Initiation Dynamics and Freezing in Parkinson's Disease

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to investigate the relationships among subthalamic nucleus (STN) activity, gait initiation (GI), and freezing of gait (FOG) in patients with Parkinson's disease (PD). Methods We recorded GI and STN local field potentials (LFPs) via externalized cables in 38 patients with PD (35 reporting FOG in daily life ...
Antoine Collomb‐Clerc   +12 more
wiley   +1 more source

Juvenile absence epilepsy: integrating photosensitivity and autonomic focal epileptic symptoms. [PDF]

open access: yesActa Neurol Belg, 2023
León-Ruiz M   +2 more
europepmc   +1 more source

A balanced translocation disruptsSYNGAP1in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA) [PDF]

open access: bronze, 2011
Laura L. Klitten   +5 more
openalex   +1 more source

Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model

open access: yesNeurotherapeutics, 2017
A. Leo   +7 more
semanticscholar   +1 more source

Widespread Skin Telangiectasias in Spinocerebellar Ataxia Type 27B

open access: yes
Annals of Neurology, EarlyView.
Victor Alm   +3 more
wiley   +1 more source

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy

open access: yesAnnals of Neurology, EarlyView.
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy